$0.69
Value $40M
TELA and UNH stock compared: price, dividend, valuation and results, from SEC filings.
$0.69
Value $40M
$339.85
Value $308B
TELA Bio (TELA) has a market value of $40M and UnitedHealth (UNH) $308B. Over the last year, with dividends, TELA moved -36.2% and UNH +12.9%. Dividend yield: TELA none, UNH 2.67%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
TELA$40M
UNH$308B
UNH is 7,766 times TELA
Revenue, 12 months
TELA$78M
UNH$450B
UNH is 5,752 times TELA
Net income, 12 months
TELA-$42M
UNH$15.9B
Operating margin
TELA-43.2%
UNH5.3%
48.5 points apart
ROIC
TELA-63.7%
UNH11.3%
75.0 points apart
P/E
TELA–
UNH19.4
Dividend yield
TELA0.0%
UNH2.7%
2.7 points apart
5-year return
TELA-94.5%
UNH-15.4%
79.1 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
TELA-94.5%
UNH-15.4%
| Period | TELAWith dividends | UNHWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | -36.2%Price -36.2% | +12.9%Price +10.0% |
| 3 years since November 20, 2023 | -85.9%-47.9% a yearPrice -85.9% | -32.4%-12.2% a yearPrice -36.5% |
| 5 years since November 19, 2021 | -94.5%-44.1% a yearPrice -94.5% | -15.4%-3.3% a yearPrice -22.8% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
TELATELA BioUNHUnitedHealth
| Price | $0.69 | $339.85 |
|---|---|---|
| Market value | $40M | $308B |
| Enterprise value (EV) | $129M | $354B |
| P/E | – | 19.4 |
| P/E, 5-year median | – | 25.0 |
| P/B | – | 3.0 |
| EV/EBIT | – | 14.8 |
| Free cash flow yield | – | 7.4% |
| Revenue, 12 months | $78M | $450B |
|---|---|---|
| Net income, 12 months | -$42M | $15.9B |
| Free cash flow, 12 months | -$34M | $22.8B |
| Earnings per share, 12 months | -$0.74 | $17.52 |
| Revenue growth, year on year | 15.8% | 11.8% |
| Revenue growth a year, past | +34.5%over 5 years | +11.7%over 5 years |
| EPS growth a year, past | – | -3.8%over 5 years |
| Gross margin | 67.2% | 88.3% |
|---|---|---|
| Operating margin | -43.2% | 5.3% |
| Net margin | -53.6% | 3.5% |
| ROIC | -63.7% | 11.3% |
| ROE | – | 15.5% |
| Cash | $23M | $28.5B |
|---|---|---|
| Total debt | $112M | $74.3B |
| Net debt / EBITDA | – | 1.6 |
| Interest cover | -4.3× | 6.2× |
| Dividend yield | – | 2.7% |
|---|---|---|
| Dividend per share, 12 months | – | $9.06 |
| Dividend growth a year, past | – | +12.6%over 5 years |
| Buyback yield | – | 1.8% |
| Shareholder yield | – | 4.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, UnitedHealth ($308B) is about 7,766.4 times TELA Bio ($40M), at today's prices.
Since November 19, 2021, TELA's price moved -94.5% and UNH's -22.8%. With dividends: TELA -94.5% (-44.1% a year), UNH -15.4% (-3.3% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for TELA Bio and 2.67% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.
Over the last twelve months, the net margin was -53.6% for TELA Bio and 3.5% for UnitedHealth, and the operating margin -43.2% and 5.3%. Revenue was $78M and $450B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.